For me, it's hard to imagine BOT running up from 5.5c to 11c, in one month, off the back of a pending mid cycle review, only then to stall if such an announcement increases the chances of the FDA approving SB in September. We don't already 'know' that the FDA is going to approve SB, but we do think it is likely. This review will provide a further indicator as to 'how' likely. If the FDA don't have any major issues at this stage, then I think the market will react positively in anticipation for September approval, just like it has this month in anticipation of a positive mid cycle review in Q3. Just my thoughts anyway.
For me, it's hard to imagine BOT running up from 5.5c to 11c, in...
-
- There are more pages in this discussion • 8,849 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.784M | 4.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248028 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 356327 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |